Prevalence, management, and outcome of adverse rhythm disorders in takotsubo syndrome: insights from the international multicenter GEIST registry.


Journal

Heart failure reviews
ISSN: 1573-7322
Titre abrégé: Heart Fail Rev
Pays: United States
ID NLM: 9612481

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 13 11 2019
medline: 26 3 2021
entrez: 13 11 2019
Statut: ppublish

Résumé

One important complication related to takotsubo syndrome (TTS) is adverse rhythm disorders. Our study was conducted to determine the incidence and management of adverse rhythm disorders in TTS and its long-term prognostic impact. We analyzed 906 TTS patients from 9 European centers. Patients were divided into the adverse rhythm disorders group (encompassing ventricular tachycardia, ventricular fibrillation, torsade de pointes, and asystole or complete atrioventricular block) and non-adverse rhythm disorders group. In our study cohort, we identified 67 (7.4%) patients with presence of adverse rhythm disorders. TTS patients were followed up over a period of 2.8 years. In the adverse rhythm disorders group, 18% of patients presented adverse rhythm disorders before hospital admission. Asystole and/or AV block were significantly more presented before admission (13 patients versus 8 patients; p < 0.01), whereas ventricular tachyarrhythmias were more presented in-hospital (4 patients versus 42 patients; p < 0.01). Adverse rhythm disorders patients suffered more frequently from cardiogenic shock (31% versus 7.6%, p < 0.01) and in-hospital death (10.9% versus 3.6%; p < 0.01). Furthermore, the long-term survival was significantly impaired in adverse rhythm disorders patients as compared with non-adverse rhythm disorders patients; (log-rank p < 0.01). Using multivariate Cox regression analysis, cardiogenic shock (HR 2.86, 95% CI 1.1-6.9; p = 0.02) was identified as independent predictors of adverse rhythm disorders. The short- and long-term mortality rate of TTS patients presenting with adverse rhythm disorders was significantly higher than in TTS patients presenting without it. Therefore, TTS patients with adverse rhythm disorders should be carefully monitored during hospital stay and at long-term follow-up.

Identifiants

pubmed: 31713085
doi: 10.1007/s10741-019-09856-4
pii: 10.1007/s10741-019-09856-4
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

505-511

Références

J Am Coll Cardiol. 2015 May 19;65(19):2148-50
pubmed: 25975480
Int J Cardiol. 2015 Apr 15;185:282-9
pubmed: 25818540
Eur J Heart Fail. 2016 Jan;18(1):8-27
pubmed: 26548803
Heart Rhythm. 2013 Jan;10(1):70-7
pubmed: 22975421
Heart Rhythm. 2011 Apr;8(4):555-61
pubmed: 21146632
Cardiovasc Ther. 2016 Jun;34(3):161-6
pubmed: 26946520
J Am Heart Assoc. 2017 Dec 4;6(12):
pubmed: 29203578
J Am Soc Echocardiogr. 2010 Jul;23(7):766-71
pubmed: 20620862
JAMA. 2011 Jul 20;306(3):277-86
pubmed: 21771988
Int J Cardiol. 2018 Mar 1;254:195-202
pubmed: 29407091
Eur J Heart Fail. 2016 Jun;18(6):650-6
pubmed: 26990821
Int J Cardiol. 2018 Mar 15;255:140-144
pubmed: 29180264
Clin Cardiol. 2017 Nov;40(11):1116-1122
pubmed: 28892227
Heart Rhythm. 2016 Oct;13(10):1979-86
pubmed: 27298201
N Engl J Med. 2015 Sep 3;373(10):929-38
pubmed: 26332547
Europace. 2018 May 1;20(5):843-850
pubmed: 28453621
Am J Physiol Heart Circ Physiol. 2015 Mar 1;308(5):H467-77
pubmed: 25527782
Diabetes Care. 2018 May;41(5):1084-1088
pubmed: 29449312

Auteurs

Ibrahim El-Battrawy (I)

First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM) University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. Ibrahim.el-battrawy@umm.de.
DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Mannheim, Germany. Ibrahim.el-battrawy@umm.de.

Francesco Santoro (F)

Department of Medical and Surgery Sciences, University of Foggia, Foggia, Italy.

Thomas Stiermaier (T)

Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research (DZHK), University Heart Center Lübeck, partner site Hamburg/Kiel/Lübeck, Lübeck, Germany.

Christian Möller (C)

Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research (DZHK), University Heart Center Lübeck, partner site Hamburg/Kiel/Lübeck, Lübeck, Germany.

Francesca Guastafierro (F)

Department of Medical and Surgery Sciences, University of Foggia, Foggia, Italy.

Giuseppina Novo (G)

Biomedical Department of Internal Medicine and Medical Specialties, Cardiology Unit, University of Palermo, Palermo, Italy.

Salvatore Novo (S)

Biomedical Department of Internal Medicine and Medical Specialties, Cardiology Unit, University of Palermo, Palermo, Italy.

Andrea Santangelo (A)

Biomedical Department of Internal Medicine and Medical Specialties, Cardiology Unit, University of Palermo, Palermo, Italy.

Enrica Mariano (E)

Division of Cardiology, University of Rome Tor Vergata, Rome, Italy.

Francesco Romeo (F)

Division of Cardiology, University of Rome Tor Vergata, Rome, Italy.

Fabiana Romeo (F)

Division of Cardiology, University of Rome Tor Vergata, Rome, Italy.

Holger Thiele (H)

Department of Internal Medicine/Cardiology, Heart Center Leipzig - University Hospital, Leipzig, Germany.

Federico Guerra (F)

Cardiology and Arrhythmology Clinic, University Hospital "Umberto I-Lancisi-Salesi", Marche Polytechnic University, Ancona, Italy.

Alessandro Capucci (A)

Cardiology and Arrhythmology Clinic, University Hospital "Umberto I-Lancisi-Salesi", Marche Polytechnic University, Ancona, Italy.

Irene Giannini (I)

Cardiology and Arrhythmology Clinic, University Hospital "Umberto I-Lancisi-Salesi", Marche Polytechnic University, Ancona, Italy.

Pasquale Caldarola (P)

Department of Cardiology, San Paolo Hospital, Bari, Italy.

Natale Daniele Brunetti (ND)

Department of Medical and Surgery Sciences, University of Foggia, Foggia, Italy.

Ingo Eitel (I)

Medical Clinic II (Cardiology/Angiology/Intensive Care Medicine) and German Center for Cardiovascular Research (DZHK), University Heart Center Lübeck, partner site Hamburg/Kiel/Lübeck, Lübeck, Germany.

Ibrahim Akin (I)

First Department of Medicine, Faculty of Medicine, University Medical Centre Mannheim (UMM) University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site, Heidelberg-Mannheim, Mannheim, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH